R-CHOP is indeed the standard first-line treatment for DLBCL, especially given that your mother's lymphoma is CD20+, which means rituximab (the "R" in R-CHOP) can directly target the cancer cells. It's a well-established combination of chemotherapy and immunotherapy that has helped many people.
R-CHOP stands for
- R – Show Full Answer
R-CHOP is indeed the standard first-line treatment for DLBCL, especially given that your mother's lymphoma is CD20+, which means rituximab (the "R" in R-CHOP) can directly target the cancer cells. It's a well-established combination of chemotherapy and immunotherapy that has helped many people.
R-CHOP stands for:
- R – Rituximab (targets CD20+ lymphoma cells)
- C – Cyclophosphamide
- H – Doxorubicin
- O – Vincristine
- P – Prednisone
R-CHOP cures roughly 60–70% of newly diagnosed DLBCL cases, and more than 3 out of 4 people reach complete remission. That said, your mother's case shows some high-risk features — widespread disease, very high LDH, and a high Ki-67 — which may place her in a higher-risk category. Her care team will factor all of this in. It's also worth knowing that in 2023, the FDA approved a newer option called Pola-R-CHP, which replaces vincristine with polatuzumab vedotin (Polivy) — a drug that delivers chemotherapy directly to lymphoma cells. Some oncologists now prefer this for higher-risk DLBCL. It may be worth asking her doctor whether Pola-R-CHP could be considered for her case. Here are some practical ways to support her through treatment and improve outcomes:
- Stay closely engaged with her oncology team — given her high-risk features, frequent monitoring (PET/CT scans mid-treatment) is important to assess how well R-CHOP is working
- Monitor her blood counts carefully — her low hemoglobin means fatigue will likely be significant; her team should track this closely throughout treatment
- Ask about second-line options early — if R-CHOP doesn't achieve full remission, treatments like CAR T-cell therapy are available and have shown strong results for relapsed DLBCL
- Nutrition and rest — supporting her body through treatment with good nutrition and adequate rest can help her tolerate the cycles better
- Infection prevention — chemotherapy lowers immunity, so avoiding infections (hand hygiene, avoiding sick contacts) is especially important
The fact that treatment is already underway is a positive step. Her team will reassess response after a few cycles, which will give a clearer picture of how things are going.
September 8
Join
Your Privacy Choices
